Press room

The UK-based medical cannabis ecosystem provider has received funding from Leafy Tunnel, a venture capital fund investing in European medical cannabis and global medical psychedelics companies. Sharp Capital Advisors, a leading US cannabis advisory firm also participated as an investor in the round. The funds are being used for expansion into multiple markets across Europe … Continued

Recently, LYPHE Group CEO and Co-Founder Jonathan Nadler spoke to Christopher Sharp at the Daily Express on medical cannabis, the challenges the industry faces and what the next steps need to be.   “1.4 million people roughly are consuming illegally for medical reasons. There should be a lot more of those patients that have access … Continued

In a UK first, LYPHE Group and Four 20 Pharma GmbH have partnered to bring Four 20 Pharma GmbH’s 100% natural unirradiated medical cannabis to the UK. This is the first time Four 20 Pharma have operated in the UK and the first batch of their ‘420 NATURAL’ product has already arrived in the UK, … Continued